Leerink Partnrs Brokers Lift Earnings Estimates for BMRN
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of BioMarin Pharmaceutical in a report released on Wednesday, February 19th. Leerink Partnrs analyst J. Schwartz now forecasts that the biotechnology company will post earnings per share of $0.94 for the quarter, up from […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of BioMarin Pharmaceutical in a report released on Wednesday, February 19th. Leerink Partnrs analyst J. Schwartz now forecasts that the biotechnology company will post earnings per share of $0.94 for the quarter, up from […]
